Top Markets
Coin of the day
Grace Therapeutics, Inc. Grace Therapeutics, Inc.

Grace Therapeutics, Inc.

GRCE
Rangering i aksjer #27034
Grace Therapeutics, Inc. specializes in the creation and commercialization of... Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betamethasone spray intended for the management of ataxia-telangiectasia, and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. Established in 2002, the enterprise previously operated under the name Acasti Pharma Inc., before officially adopting Grace Therapeutics, Inc. in October 2024. The company's main offices are located in Princeton, New Jersey.
Aksjekurs
$2.18
Sist synkronisert: 2026-08-19
Markedsverdi
$35.55M
Endring (1 dag)
2.57%
Endring (1 år)
-33.19%
Land
US
Handel Grace Therapeutics, Inc. (GRCE)

Kategori

Historikk for aksjesplitt for Grace Therapeutics, Inc. (GRCE)
Aksjen Grace Therapeutics, Inc. (symbol: GRCE) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 20, 2026.
Én GRCE-aksje kjøpt før Aug 20, 2026 tilsvarer i dag 0 GRCE-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH